Summary of worldwide pediatric malignancies reported after exposure to etanercept
Summary of worldwide pediatric malignancies reported after exposure to etanercept
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Concerns have been raised about a potential link between the use of TNF inhibitors and development of malignancy in the pediatric population. We examined the worldwide experience of etanercept use in pediatric patients and the occurrence of malignancies as reported from clinical trials, registry studies, post-marketing surveillance, and published s...
Alternative Titles
Full title
Summary of worldwide pediatric malignancies reported after exposure to etanercept
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_52e2ab88a4b242dfbc7b5d0e606b2597
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_52e2ab88a4b242dfbc7b5d0e606b2597
Other Identifiers
ISSN
1546-0096
E-ISSN
1546-0096
DOI
10.1186/1546-0096-8-18
